|
Accueil > Actualité
Merck KGaA: return to profitable growth in 2024
(CercleFinance.com) - German chemicals and pharmaceuticals group Merck KGaA announced on Thursday that it had returned to profitable growth in 2024, thereby achieving its financial targets for the year.
Net sales amounted to E21.2bn, representing organic growth of 2%, while operating profit (Ebitda) rose by 6.9% on an organic basis, to E6.1bn. The Darmstadt-based group explained that it had benefited from the commercial dynamism of all its health-related businesses and its materials activities dedicated to semiconductors. Its life sciences business returned to positive growth in H2. Merck - which will propose a stable annual dividend of E2.2 per share - said it expects net sales of E21.5bn to E22.9bn in 2025, with Ebitda of E6.1bn to E6.6bn. Following these announcements, the share was up around 2.5% on Thursday in Frankfurt, outperforming a fairly flat DAX index (+0.2%). Copyright (c) 2025 CercleFinance.com. All rights reserved. |
10/04/2025 18:30
Argansigne un bail BEFA pour un nouvel entrepôt 'Aut0nom' 10/04/2025 18:20 Eurazeoinvestit dans Ekoscan Integrity Group (EIG) 10/04/2025 18:10 Colascontrat de 100ME sur 7 ans pour la filiale canadienne 10/04/2025 16:50 GE HealthCarepartenariat avec Cincinnati Children's 10/04/2025 16:38 Fordle titre recule, Goldman Sachs passe à 'neutre' 10/04/2025 16:23 LNA SantéFlorac Investissements à plus de 5% des votes Tous les articles sociétés |
